Jay Philip Siegel - May 31, 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Lynn M. Cilinski, Attorney-in-fact
Stock symbol
MGNX
Transactions as of
May 31, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 04:52 PM
Previous filing
May 23, 2022
Next filing
May 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Stock Option (right to buy) Award $0 +19K $0.00 19K May 31, 2023 Common Stock 19K $4.67 Direct F1
transaction MGNX Restricted Stock Unit Award $0 +4.5K $0.00 4.5K May 31, 2023 Common Stock 4.5K $0.00 Direct F2, F3
transaction MGNX Stock Option (right to buy) Award $0 +21.5K $0.00 21.5K May 31, 2023 Common Stock 21.5K $4.67 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.
F3 The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
F4 At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.